Polen Capital Repligen Corp Transaction History
Polen Capital Management LLC
- $38.7 Billion
- Q3 2024
A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Repligen Corp stock. As of the latest transaction made, Polen Capital Management LLC holds 35,383 shares of RGEN stock, worth $5.09 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,383
Previous 14,572
142.81%
Holding current value
$5.09 Million
Previous $1.84 Million
186.76%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$919 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$725 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$234 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$204 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.98B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....